An evaluation of MR based deep learning auto-contouring for planning head and neck radiotherapy.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
05 2021
Historique:
received: 15 10 2020
revised: 02 02 2021
accepted: 15 02 2021
pubmed: 27 2 2021
medline: 21 5 2021
entrez: 26 2 2021
Statut: ppublish

Résumé

Auto contouring models help consistently define volumes and reduce clinical workload. This study aimed to evaluate the cross acquisition of a Magnetic Resonance (MR) deep learning auto contouring model for organ at risk (OAR) delineation in head and neck radiotherapy. Two auto contouring models were evaluated using deep learning contouring expert (DLCExpert) for OAR delineation: a CT model (model Model A deep learning MR auto-contouring model shows promise for OAR auto-contouring with statistically improved performance vs a CT based model. Performance is affected by the method of MR acquisition and further work is needed to improve its use with MRL images.

Identifiants

pubmed: 33636229
pii: S0167-8140(21)06081-3
doi: 10.1016/j.radonc.2021.02.018
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112-117

Subventions

Organisme : Cancer Research UK
ID : A21993
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C147/A25254
Pays : United Kingdom

Informations de copyright

Crown Copyright © 2021. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

C Hague (C)

Department of Head and Neck Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: Christina.hague@nhs.net.

A McPartlin (A)

Department of Head and Neck Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: Andrew.mcpartlin@nhs.net.

L W Lee (LW)

Department of Head and Neck Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: lipwai.lee@nhs.net.

C Hughes (C)

Department of Head and Neck Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: christopher.hughes@christie.nhs.uk.

D Mullan (D)

Department of Radiology, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: Damian.mullan@nhs.net.

W Beasley (W)

Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: w.beasley@nhs.net.

A Green (A)

Division of Cancer Sciences, Faculty of Biology, Medicine and Heath, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: Andrew.green-2@manchester.ac.uk.

G Price (G)

Division of Cancer Sciences, Faculty of Biology, Medicine and Heath, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: Gareth.price@manchester.ac.uk.

P Whitehurst (P)

Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: Philip.whitehurst1@nhs.net.

N Slevin (N)

Department of Head and Neck Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

M van Herk (M)

Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Heath, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: marcel.vanherk@manchester.ac.uk.

C West (C)

Division of Cancer Sciences, Faculty of Biology, Medicine and Heath, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: Catharine.west@manchester.ac.uk.

R Chuter (R)

Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Heath, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: Robert.chuter@nhs.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH